ITEOS THERAPEUTICS INC's ticker is ITOS and the CUSIP is 46565G104. A total of 145 filers reported holding ITEOS THERAPEUTICS INC in Q3 2022. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $231,516 | -17.4% | 21,143 | -0.1% | 0.00% | 0.0% |
| Q2 2023 | $280,132 | -6.7% | 21,158 | -4.1% | 0.00% | -25.0% |
| Q1 2023 | $300,400 | -68.2% | 22,072 | -54.4% | 0.00% | -33.3% |
| Q4 2022 | $945,330 | +122.4% | 48,404 | +117.2% | 0.01% | 0.0% |
| Q3 2022 | $425,000 | +5.5% | 22,287 | +13.8% | 0.01% | +20.0% |
| Q2 2022 | $403,000 | -33.6% | 19,579 | +3.8% | 0.01% | -28.6% |
| Q1 2022 | $607,000 | – | 18,864 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| MPM ASSET MANAGEMENT LLC | 2,738,785 | $29,989,696 | 16.06% |
| MPM BioImpact LLC | 1,745,943 | $19,118,076 | 5.10% |
| Saturn V Capital Management LP | 994,756 | $10,892,578 | 4.56% |
| Boxer Capital, LLC | 1,804,058 | $19,754,435 | 1.05% |
| RA Capital Management | 4,417,259 | $48,368,986 | 0.95% |
| 683 Capital Management, LLC | 810,000 | $8,869,500 | 0.69% |
| Ikarian Capital, LLC | 346,471 | $3,793,857 | 0.46% |
| Ikarian Capital, LLC | 3,056 | $3,346,320 | 0.40% |
| BVF INC/IL | 1,259,476 | $13,791,262 | 0.37% |
| DAFNA Capital Management LLC | 98,560 | $1,079,232 | 0.34% |